References and Publications
Adolescents' Vaccine Preventable Diseases

General

• Gargano LM, et al. Multicomponent interventions to enhance influenza vaccine delivery to adolescents. Pediatrics. 2011 Nov;128(5):e1092-9.
• Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM. Adolescent Vaccination-Coverage Levels in the United States: 2006-2009 [336 KB, 11 pages]. Pediatrics. 2011 Nov 14. [Epub ahead of print]
• Lindley MC, Smith PJ, Rodewald LE. Vaccination Coverage Among U.S. Adolescents Aged 13-17 Years Eligible for the Vaccines for Children Program, 2009. Public Health Rep. 2011;126 Suppl 2:124-34.
• Stokley S, Vogt T, Shefer A. Increasing Adolescent Vaccination Coverage: The Challenges That Remain. Arch Pediatr Adolesc Med. 2011; 165(6): 568-70.
• For Everyone: Easy-to-read Schedules
• Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book) 2011.

Adolescent Reminder/Recall Systems

• Clark SJ, Butchart A, Kennedy A, Dombkowski KJ. Parents' experiences with and preferences for immunization reminder/recall technologies. Pediatrics. 2011 Nov;128(5):e1100-5.
• Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin, A. Effectiveness of a Citywide Patient Immunization Navigator Program on Improving Adolescent Immunizations and Preventive Care Visit Rates. Arch Pediatr Adolesc Med. 2011; 165(6):547-553.
• AAP Childhood Immunization Support Program. Immunization Reminder/Recall Systems [123 KB, 2 pages].
• Guide to Community Preventive Services. Universally recommended vaccines: client reminder and recall systems. Last updated: March 18, 2010. Accessed September 8, 2010.
• Kharbanda EO, Stockwell MS, Fox HW, Rickert VI. Text4Health: a qualitative evaluation of parental readiness for text message immunization reminders. Am J Public Health. 2009;99:2176-8.

Top of Page

Tdap and Tetanus, Diphtheria, Pertussis

• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR. 2011;60(01):13-15.
• Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010;28:8001-7.
• Wei S, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine (Tdap) against pertussis. Clin Infect Dis. 2010;51:315-21.
• Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(6):817-40.
• AAP Policy Statement. Prevention of pertussis among adolescents: recommendations for use of Tdap. Pediatrics. 2006;117(3):965-978.
• Davis MM, Broder KR, Cowan AE, et al. Physician attitudes and preferences about Combined Tdap vaccines for adolescents. Am J Prev Med 2006;31(2):176-180.
• Halperin SA, Sweet L, Baxendale D, et al. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J. 2006;25(3):195-200.
• Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines — Recommendations of the Advisory Committee on Immunization Practices (ACIP)[473 KB, 50 pages]. MMWR. 2006;55(R3).
• Pichichero ME, Rennels MB, Edwards KM, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA. 2005;293(24):3003-11. Erratum in: JAMA. 2005;294(24):3092.
• Brennan M, Strebel P, George H, Yih W, Tachdjian R, Lett S, et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis. 1999;181:210-5.

Top of Page

Meningitis and MCV4

For a complete list, consult the meningococcal web site references and publications.

 

HPV Vaccine

• Kahn, et al. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics. 2012. [Epub ahead of print]
• Human Papillomavirus–Associated Cancers — United States, 2004–2008. MMWR. 2012;61(15):258-61.
• Gillison, ML, et al. Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA. 2012; Published online January 26, 2012. doi:10.1001/jama.2012.101
• Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011;60(50):1705-8.
• Leader AE, et al. An Exploratory Study of Adolescent Female Reactions to Direct-to-Consumer Advertising: The Case of the Human Papillomavirus (HPV) Vaccine. Health Marketing Quart. 2011;28(4):372-385.
• Liddon NC, Leichliter JS, Markowitz LE. Human Papillomavirus Vaccine and Sexual Behavior Among Adolescent and Young Women. Am J Prev Med. 2012;42(1):44–52.
• Dorell CG, Stokley S, Yankey D, Markowitz LE. Compliance with recommended dosing intervals for HPV vaccination among females, 13–17 years, National Immunization Survey-Teen, 2008–2009. Vaccine. 2012; 30(3):503–505.
• Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human Papillomavirus Vaccination Series Initiation and Completion, 2008-2009. Pediatrics. 2011 Nov;128(5):830-839. Epub 2011 Oct 17.
• Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The cost-effectiveness of male HPV vaccination in the United States Vaccine. 2011.
• Saraiya M, Hariri S. HPV vaccine effect: is the glass half full or half empty? [274 KB, 2 pages] Lancet. 2011;377(9783):2057-8.
• Brotherton JML, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study [244 KB, 8 pages]. Lancet. 2011;377:2085–92.
• Kilgore, C. How to meet the hpv counseling and vaccination challenge. Pediatric News. 2011;45:1-2.
• Widdice, L, et al. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;27(1):77-84.
• Cook, R et. al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in medicaid. Journal of Adolescent Health. 2010; 47:596-599.
• FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(20):626-629
• FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR. 2010;59(20):630-632
• Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010;125(5):982-9.
• U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2006 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010.

Top of Page

Flu Vaccine

• Prevention and Control of Influenza with Vaccines - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 [1.16 MB, 68 pages]. MMWR. 2010;59(RR-8).
• Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010;202(11):1626-33.
• Muhammad RD, Haber P, Broder KR, et al. Adverse events following trivalent inactivated influenza vaccination in children: analysis of the vaccine adverse event reporting system. Pediatr Infect Dis J 2010.
• Poland GA. The 2009-2010 Influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010.
• Uscher-Pines L, Maurer J, Kellerman A, Harris KM. Healthy young and middle age adults: what will it take to vaccinate them for influenza? Vaccine. 2010.

More can be found at references and resources on CDC's flu web site

Top of Page